RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer

Clinical trial NCT04575363 · RECRUITING

Trial details

NCT number: NCT04575363
Sponsor: CHU de Reims
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)

Start date: 2021-10-18
Primary completion: 2026-10-18
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.